PMID- 28292012 OWN - NLM STAT- MEDLINE DCOM- 20180226 LR - 20180226 IS - 1950-6007 (Electronic) IS - 0753-3322 (Linking) VI - 89 DP - 2017 May TI - Up regulation of IL-6 is involved in di (2-ethylhexyl) phthalate (DEHP) induced migration and invasion of non small cell lung cancer (NSCLC) cells. PG - 1037-1044 LID - S0753-3322(16)33005-0 [pii] LID - 10.1016/j.biopha.2017.02.107 [doi] AB - Di (2-ethylhexyl) phthalate (DEHP), which is widely used in polyvinyl chloride materials, can be easily accumulated into human body. Lung cancer cells can be directly exposed to DEHP via inhalation, however, the effects and related mechanisms of DEHP on the progression of non small cell lung cancer (NSCLC) were not illustrated. Our present study revealed that DEHP less than 10(-4)M had no significant effect on the proliferation of A549 or H1299 cells, while nanomolar DEHP can trigger the migration and invasion of NSCLC cells. DEHP treatment also increased the expression of interleukin-6 (IL-6) and IL-8. Silencing of IL-6, while not IL-8, can attenuate DEHP induced migration and invasion of NSCLC cells. This was confirmed by result that neutralization antibody of IL-6, while not anti-IL-8, attenuated DEHP induced invasion of A549 cells. The inhibitor of NF-kappaB, while not ERK1/2 or Akt, abolished DEHP induced up regulation of IL-6 and invasion of NSCLC cells. DEHP treatment can increase the phosphorylation, nuclear localization, and transcriptional activities of p65, one of the major parts of NF-kappaB complex. Collectively, our study revealed that DEHP can stimulate NSCLC migration and invasion via NF-kappaB mediated up regulation of IL-6. CI - Copyright (c) 2017 Elsevier Masson SAS. All rights reserved. FAU - Wang, Yingyi AU - Wang Y AD - Oncology Department of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Dongcheng District, Beijing, 100730, PR China. FAU - Zhao, Ming AU - Zhao M AD - Thoracic Surgery Department of China PLA General Hospital, No.28 Fuxing Road, Haidian District, Beijing, 100853, PR China. FAU - Liu, Jieying AU - Liu J AD - Oncology Department of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Dongcheng District, Beijing, 100730, PR China. FAU - Ni, Jianjiao AU - Ni J AD - Peking Union Medical College, Chinese Academy of Medical Sciences, Dongcheng District, Beijing, 100005, PR China. FAU - Jiao, Yuchen AU - Jiao Y AD - Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Chaoyang District, Beijing, 100021, PR China. FAU - Bai, Chunmei AU - Bai C AD - Oncology Department of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Dongcheng District, Beijing, 100730, PR China. Electronic address: chunmeibai@126.com. LA - eng PT - Journal Article DEP - 20170310 PL - France TA - Biomed Pharmacother JT - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie JID - 8213295 RN - 0 (Interleukin-6) RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) RN - C42K0PH13C (Diethylhexyl Phthalate) SB - IM MH - Carcinoma, Non-Small-Cell Lung/*metabolism MH - Cell Line, Tumor MH - Cell Movement/*drug effects MH - Diethylhexyl Phthalate/*pharmacology MH - Gene Expression Regulation, Neoplastic/drug effects MH - Humans MH - Interleukin-6/genetics/*metabolism MH - Interleukin-8/genetics/metabolism MH - NF-kappa B MH - Neoplasm Invasiveness/*physiopathology MH - Up-Regulation/*drug effects OTO - NOTNLM OT - DEHP OT - IL-6 OT - Invasion OT - NF-kappaB OT - NSCLC EDAT- 2017/03/16 06:00 MHDA- 2018/02/27 06:00 CRDT- 2017/03/16 06:00 PHST- 2016/12/31 00:00 [received] PHST- 2017/02/18 00:00 [revised] PHST- 2017/02/28 00:00 [accepted] PHST- 2017/03/16 06:00 [pubmed] PHST- 2018/02/27 06:00 [medline] PHST- 2017/03/16 06:00 [entrez] AID - S0753-3322(16)33005-0 [pii] AID - 10.1016/j.biopha.2017.02.107 [doi] PST - ppublish SO - Biomed Pharmacother. 2017 May;89:1037-1044. doi: 10.1016/j.biopha.2017.02.107. Epub 2017 Mar 10.